| Literature DB >> 34910151 |
Manuel M Montero-Odasso1,2,3, Nellie Kamkar2, Frederico Pieruccini-Faria2,3, Abdelhady Osman3, Yanina Sarquis-Adamson2, Jacqueline Close4,5, David B Hogan6, Susan Winifred Hunter7,8, Rose Anne Kenny9, Lewis A Lipsitz10, Stephen R Lord11,12, Kenneth M Madden13,14, Mirko Petrovic15, Jesper Ryg16,17, Mark Speechley3,18, Munira Sultana2, Maw Pin Tan19,20, N van der Velde21, Joe Verghese22,23, Tahir Masud16,17,24.
Abstract
Importance: With the global population aging, falls and fall-related injuries are ubiquitous, and several clinical practice guidelines for falls prevention and management for individuals 60 years or older have been developed. A systematic evaluation of the recommendations and agreement level is lacking.Entities:
Mesh:
Year: 2021 PMID: 34910151 PMCID: PMC8674747 DOI: 10.1001/jamanetworkopen.2021.38911
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-analyses Flowchart of Search Yield
AGREE-II indicates Appraisal of Guidelines for Research & Evaluation II.
aRecords suggested by 3 of us who are experts in the field of geriatric medicine (M.M.M.-O., S.R.L., and T.M.).
Quality Assessment Total and Domain-Specific Scores of the Guidelines Using AGREE-II
| Source or guideline | AGREE-II total score, % | AGREE-II domain scores, % | |||||
|---|---|---|---|---|---|---|---|
| 1: Scope and purpose | 2: Stakeholder involvement | 3: Rigor of development | 4: Clarity of presentation | 5: Applicability | 6: Editorial independence | ||
| Baraff et al,[ | 78.5 | 96.3 | 81.5 | 72.2 | 88.9 | 62.5 | 88.9 |
| AGILE,[ | 74.6 | 94.4 | 68.5 | 66.7 | 94.4 | 56.9 | 91.7 |
| Feder et al,[ | 77.8 | 92.6 | 66.7 | 81.9 | 81.5 | 54.2 | 97.2 |
| AGS/BGS/AAOS,[ | 84.5 | 94.4 | 81.5 | 82.6 | 96.3 | 66.7 | 100 |
| Moreland et al,[ | 80.0 | 96.3 | 68.5 | 80.6 | 83.3 | 66.7 | 91.7 |
| ACSQHC,[ | 81.9 | 94.4 | 83.3 | 68.8 | 94.4 | 79.2 | 100 |
| FSGG,[ | 78.0 | 92.6 | 74.1 | 75.0 | 85.2 | 59.7 | 100 |
| NICE,[ | 92.8 | 98.1 | 94.4 | 91.7 | 92.6 | 86.1 | 100 |
| STEADI,[ | 74.2 | 90.7 | 81.5 | 66.7 | 81.5 | 58.3 | 88.9 |
| Jung et al,[ | 77.5 | 90.7 | 64.8 | 77.8 | 90.7 | 56.9 | 97.2 |
| RACGP,[ | 69.7 | 83.3 | 72.2 | 58.3 | 83.3 | 54.2 | 100 |
| KAIM/KGS,[ | 80.4 | 79.6 | 81.5 | 86.8 | 90.7 | 51.4 | 97.2 |
| RNAO,[ | 88.0 | 94.4 | 86.1 | 84.4 | 88.9 | 85.4 | 100 |
| SENATOR ONTOP,[ | 79.2 | 94.4 | 61.1 | 86.1 | 85.2 | 52.8 | 100 |
| USPSTF,[ | 82.9 | 92.6 | 79.6 | 82.6 | 96.3 | 59.7 | 100 |
| Mean (SD) [range] | 80.1 (5.6) [69.7-92.8] | 92.3 (4.8) [79.6-98.1] | 76.3 (9.0) [61.1-94.4] | 77.6 (9.3) [58.3-91.7] | 88.7 (5.4) [81.5-96.3] | 63.4 (11.4) [51.4-86.1] | 96.9 (4.2) [88.9-100] |
Abbreviations: ACSQHC, Australian Commission on Safety and Quality in Health Care; AGILE, a recognized professional network of the Chartered Society of Physiotherapy; AGREE-II, Appraisal of Guidelines for Research & Evaluation–II; AGS/BGS/AAOS, American Geriatrics Society/British Geriatrics Society/American Academy of Orthopaedic Surgeons; FSGG, French Society of Geriatrics and Gerontology; KAIM/KGS, Korean Association of Internal Medicine/Korean Geriatrics Society; NICE, National Institute for Health and Care Excellence; RACGP, The Royal Australian College of General Practitioners; RNAO, Registered Nurses’ Association of Ontario; SENATOR ONTOP, software engine for the assessment & optimization of drug and non-drug therapy—older persons optimal evidence-based non-drug therapies in older people; STEADI, Stopping Elderly Accidents, Deaths and Injuries; USPSTF, US Preventive Services Task Force.
Scores range from 0 to 100, with higher scores indicating higher quality.
Figure 2. Mean Appraisal of Guidelines for Research & Evaluation II (AGREE-II) Total and Domain-Specific Scores Across Guidelines[31]
Guidelines Appraised With Evidence and Strength for Each Recommendation Stratified by Topic Areas Identified
| 16 Areas identified | No. (%) of guidelines addressing this area | Mode of GRADE score | GRADE agreement Fleiss | 15 Guidelines included | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baraff et al,[ | AGILE,[ | Feder et al,[ | AGS/BGS/AAOS,[ | Moreland et al,[ | ACSQHC,[ | FSGG,[ | NICE,[ | STEADI,[ | Jung et al,[ | RACGP,[ | KAIM/KGS,[ | RNAO,[ | SENATOR ONTOP,[ | USPSTF,[ | ||||
| Risk stratification | 13 (87) | 1A | .92 | NA | 1A | 1A | 1A | 1A | 1A | 1C | 1B | 1A | 1A | 1A | 1C | 1A | NA | 1A |
| Assessment tools | 15 (100) | 1A | .88 | 1A | 1A | 1B | 1A | 1A | 1A | 1C | 1A | 1A | 1A | 1A | 1C | 1B | 1B | 1A |
| Fractures and osteoporosis management | 11 (73) | 1A | .83 | 1A | 1A | NA | NA | NA | 1A | 1C | 1A | 1A | 2B | 1A | 1A | 1C | NA | 1A |
| Multifactorial interventions | 14 (93) | 1A | .82 | NA | 1A | 1A | 2B | 1B | 1A | 1C | 1A | 1C | 1A | 1A | 1A | 1A | 1C | 1C |
| Medication review | 14 (93) | 1A | .68 | 1A | 1B | NA | 1C | 1A | 1B | 1C | 1A | 1A | 1A | 1A | 1C | 1A | 1B | 2C |
| Exercise interventions | 15 (100) | 1A | .88 | 1A | 1A | 1B | 1B | 1B | 1A | 1C | 1A | 1B | 1A | 1A | 1A | 1A | 1B | 1B |
| Vitamin D supplementation | 11 (73) | Mixed | .30 | 1A | NA | NA | 2C | NA | 1A | 1C | 2C | 1A | 1A | 1A | 2C | 1B | NA | 2C |
| Hip protectors | 9 (60) | Underrep | .69 | NA | NA | 1B | 1C | NA | 1A | 2C | 2B | 1A | 1A | NA | NA | 1B | NA | 1A |
| Vision modification | 13 (87) | 1B | .66 | 1A | NA | NA | 1C | 1B | 2B | 1C | 1B | 1A | 1A | 1A | 1C | 2C | 1B | 1B |
| Environment modification | 14 (93) | 1A | .70 | 1B | 1A | 1B | 1B | 1A | 1A | 1C | 1A | 1A | 1A | 1A | 1C | 1A | NA | 2C |
| Cognitive factors management | 11 (73) | Mixed | .39 | 1B | NA | NA | 1B | 1B | 1C | 1C | 2C | 1B | 1A | 1A | NA | 2C | NA | 2C |
| Physiotherapy referral | 13 (87) | 1A | .50 | 1A | 2B | NA | 1B | 1B | 1A | 1C | 1B | 1A | 1A | NA | 1A | 2C | 1C | 2B |
| Falls education | 12 (80) | Mixed | .20 | NA | 2C | 2A | 2B | 2C | 1A | 1C | 1B | 1B | 1A | NA | NA | 1A | 2B | 2B |
| Cardiovascular intervention | 13 (87) | 1B | .61 | 1B | 2C | 1B | 1C | 1B | 1B | 1C | 1B | 1B | 1A | 1A | 1C | NA | NA | 1C |
| Footwear evaluation and intervention | 12 (80) | 1A | .42 | 1B | 2B | NA | 2C | 1B | 2C | 1C | 1A | 1A | NA | 1A | 1C | 1A | NA | 2C |
| Technology | 7 (47) | Underrep | .78 | NA | NA | NA | 1C | 1B | NA | NA | NA | 1C | 1A | NA | NA | 2B | 1B | 1C |
| Areas addressed in each guideline (of 16), % | 69 | 75 | 50 | 94 | 81 | 94 | 100 | 94 | 100 | 94 | 75 | 75 | 100 | 50 | 100 | |||
| Setting of intended recommendations | ||||||||||||||||||
| Community dwelling | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
| Nursing homes | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||
| Acute care and hospitals | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||
Abbreviations: ACSQHC, Australian Commission on Safety and Quality in Health Care; AGILE, a recognized professional network of the Chartered Society of Physiotherapy; AGS/BGS/AAOS, American Geriatrics Society/British Geriatrics Society/American Academy of Orthopaedic Surgeons; FSGG, French Society of Geriatrics and Gerontology; GRADE, Grades of Recommendation, Assessment, Development, and Evaluation; KAIM/KGS, Korean Association of Internal Medicine/Korean Geriatrics Society; NA, not available; NICE, National Institute for Health and Care Excellence; RACGP, The Royal Australian College of General Practitioners; RNAO, Registered Nurses’ Association of Ontario; SENATOR ONTOP, software engine for the assessment & optimization of drug and non-drug therapy—older persons optimal evidence-based non-drug therapies in older people; STEADI, Stopping Elderly Accidents, Deaths and Injuries; Underrep, Underrepresented; USPSTF, US Preventive Services Task Force.
GRADE strength of recommendation (1 = strong; 2 = weak) and quality of evidence (A = high quality; B = moderate quality; C = low quality).
The check mark indicates setting of intended recommendation.
Description of Risk Stratification by Guidelines and Use of an Algorithm
| Guidelines identified | Determination steps for risk assessment in the recommendations | Gaps and areas to expand | |||||
|---|---|---|---|---|---|---|---|
| Stratification method | Fall history | Age, y | Sex | Gait, balance, and mobility assessment | Other | ||
| Baraff,[ | Narrative | Any previous falls | NA | NA | TUG test | NA | Absence of a clear risk stratification methods algorithm |
| AGILE,[ | NA | NA | NA | NA | NA | NA | |
| Feder et al,[ | NA | NA | NA | NA | NA | NA | |
| AGS/BGS/AAOS,[ | Algorithm | 1 Fall in 12 mo: gait and balance evaluation; recurrent falls in 12 mo or an acute fall or difficulty with walking and balance: fall evaluation[ | NA | NA | TUG test | NA | Individuals with no fall history or low (1 fall) fall history may fall and require fall evaluation[ |
| Moreland et al,[ | Narrative | NA | ≥74 | Female | Tinetti Performance-Oriented Assessments of Gait and Balance | NA | Fall history is not included in risk stratification |
| ACSQHC,[ | Narrative | Any previous fall | NA | NA | List of assessment tool options | NA | Demographic risk factors |
| FSGG,[ | Algorithm | 1 Fall in 12 mo: gait and balance evaluation; recurrent falls in 12 mo or an acute fall or difficulty with walking and balance: fall evaluation[ | ≥80 | Female | TUG test | Multiple risk factors[ | Individuals with no fall history or low (1 fall) fall history may fall and require fall evaluation[ |
| NICE,[ | Narrative | ≥1 Fall or emergency department visit for fall: multifactorial risk assessment | NA | NA | List of assessment tool options | Gait or balance problems | Broad list of assessment tools |
| STEADI,[ | Algorithm | ≥1 Fall in 12 mo: multifactorial risk assessment; low risk (no fall history): patient education and referral to community exercise, balance, fitness, or fall prevention program | NA | NA | TUG test, 4-stage balance test | Fear of falling | Demographic risk factors |
| Jung et al,[ | Algorithm | ≥1 Fall in 12 mo: comprehensive intervention; low risk (no fall history) regular checkups | NA | NA | Gait or balance problems | Polypharmacy, dementia, general diseases, cognition, fall-related symptoms, physical fitness, environmental factors, and aids | Details pertaining to assessment tools |
| RACGP,[ | Table | ≥1 Fall with multiple risk factors in 12 mo: risk factor screening and preventive activities; low risk (no fall history): yearly fall screening | ≥65 | NA | Gait or balance and mobility difficulties | Clinical judgment | Broad list of assessment tools |
| KAIM/KGS,[ | Algorithm | ≥2 Falls in 12 mo: multifactorial falls evaluation | NA | NA | TUG test and BBS | NA | Individuals with no fall history or low (1 fall) fall history may fall and require fall evaluation[ |
| RNAO,[ | Narrative | Any previous falls: comprehensive assessment; ≥2 falls in 12 mo: clinician referral | NA | NA | Gait, balance, or mobility difficulty | Clinical judgment | Broad list of assessment tools |
| SENATOR ONTOP,[ | Narrative | Any previous falls: multifactorial intervention; low risk (no fall history): group-based exercise | ≥65 | NA | Gait problems | Walking aid, dizziness, muscle weakness, and polypharmacy | Unspecified assessments to determine risk |
| USPSTF,[ | Table | Any previous falls: multifactorial intervention | ≥65 | NA | TUG test | Physical function or mobility problems | Adults aged 60-65 y may experience falls |
Abbreviations: ACSQHC, Australian Commission on Safety and Quality in Health Care; AGILE, a recognized professional network of the Chartered Society of Physiotherapy; AGS/BGS/AAOS, American Geriatrics Society/British Geriatrics Society/American Academy of Orthopaedic Surgeons; BBS, Berg Balance Scale; FSGG, French Society of Geriatrics and Gerontology; KAIM/KGS, Korean Association of Internal Medicine/Korean Geriatrics Society; NA, not applicable; NICE, National Institute for Health and Care Excellence; RACGP, The Royal Australian College of General Practitioners; RNAO, Registered Nurses’ Association of Ontario; SENATOR ONTOP, software engine for the assessment & optimization of drug and non-drug therapy—older persons optimal evidence-based non-drug therapies in older people; STEADI, Stopping Elderly Accidents, Deaths and Injuries; TUG, Timed Up and Go; USPSTF, US Preventive Services Task Force.